来自银杏提取物的抗肿瘤化合物的研究进展  

Research Progress on Anti-tumor Compounds from Ginkgo biloba Extracts

作　　者：方静[1] 谭卫红[1] 

机构地区：[1]中国林业科学研究院林产化学工业研究所国家林业局林产化学工程重点开放性实验室,江苏南京210042

出　　处：《生物质化学工程》2008年第5期56-60,共5页Biomass Chemical Engineering

摘　　要：银杏提取物及其制剂在临床上主要用于治疗心脑血管及中枢神经系统病变。近年来在对银杏提取物的研究中,多种化合物显示出强大的体内外抗肿瘤活性。本文着重介绍了银杏叶和银杏外种皮来源的聚戊烯醇、银杏多糖、银杏酚酸等化合物抗肿瘤研究的最新进展。Ginkgo biloba Linn. extracts and their preparations were primarily used in clinical treatment of cardiovascular and cerebrovascular disease and pathological changes of central nerve system. In recent investigations, many compounds of G. biloba extracts have exhibited potent anti-tumor activities both in vitro and in vivo tumor model studies. In this review, the recent progress on the anti-tumor research of G. biloba derived polyprenols, polysaccharides and ginkgolic acids was introduced.

关 键 词：银杏提取物 抗肿瘤作用 聚戊烯醇 银杏多糖 银杏酚酸 

分 类 号：TQ461[化学工程—制药化工]